MIRXES PTE. LTD.
Overview
MIRXES PTE. LTD. (UEN 201407328H) is a live private company limited by shares in Singapore. It was registered on 14 March 2014 and has operated for 12 years. Its primary (principal) activity is research and experimental development on medical and veterinary sciences (SSIC 72106), and its secondary activity is other manufacturing industries n.e.c. (SSIC 32909). Since 2024 it has won 2 government contracts from 1 public agency. Its registered address is 2 Tukang Innovation Grove, #09-02, Jtc Medtech Hub, Singapore 618305.
About the business
Mirxes is a Singapore biotech company, spun off from A*STAR in 2014, that develops RNA-based blood tests for early cancer detection. It also offers tumour profiling tests, infectious disease test kits, multiomics sequencing and biobanking services for clinicians and researchers.
Services
- Gastric cancer blood test
- Lung cancer blood test
- NGS tumour profiling tests
- SARS-CoV-2 RT-PCR test kits
- RNA extraction kits
- Multiomics sequencing services
- miRNA detection research tools
- Biobanking and storage
- Clinical sequencing
Profile
Company information
- Legal name
- MIRXES PTE. LTD.
- UEN
- 201407328H
- Status
- Live Company
- Entity type
- Local Company
- Company type
- Private Company Limited by Shares
- Incorporated
- 14 Mar 2014 (12 years ago)
- Annual return
- 16 Dec 2025
- Accounts due
- 31 Jul 2026
- Officers
- 18
Address and contact
- Registered address
- 2 TUKANG INNOVATION GROVE, #09-02, JTC MEDTECH HUB, Singapore 618305
- Area
- Tukang, Boon Lay (West Region)
- Postal district
- D22 (Jurong)
- info@mirxes.com
- Phone
- +65 6816 2931
Website and social
- Website
- www.mirxes.com
- Social
Business activity
- Primary activity
- 72106 Research and experimental development on medical and veterinary sciences
- Secondary activity
- 32909 Other manufacturing industries n.e.c.
Government
Contracts
MIRXES PTE. LTD. won 2 government contracts from 1 public agency through GeBIZ since April 2020. The total award value is S$1,012,500.
| Tender | Awarded | Amount |
|---|---|---|
| Supply and Delivery of Stereo Sequencing for Human Liver Cancer OCT block samples.NST000ETT25000097Agency for Science, Technology and Research | 5 Feb 2026 | S$375,000 |
| Sequencing Service: PE100 Stereoseq Full Service (T7) for 85 samples of human livers.NST000ETT24000031Agency for Science, Technology and Research | 15 Oct 2024 | S$637,500 |
InvoiceNow profile
- InvoiceNow
- Registered on the Peppol network
- Name on Peppol
- MIRXES PTE. LTD.
- Peppol ID
- 0195:SGUEN201407328H
- Registered
- 25 Apr 2020